[New prospects in myocardial surgical revascularization]

Area of Science:

• Cardiovascular Medicine
• Surgical Innovation
• Regenerative Medicine

Context:

• Ischemic heart disease management relies on coronary bypass graft surgery and angioplasty.
• Refinements in surgical techniques and devices have improved outcomes.
• Optimal revascularization strategies for complex coronary artery disease remain under investigation.

Purpose:

• To review current myocardial revascularization techniques for ischemic heart disease.
• To evaluate the evidence supporting arterial conduits in coronary bypass graft surgery.
• To explore emerging therapies for refractory angina and diffuse coronary artery disease.

Summary:

• Coronary artery bypass graft surgery and angioplasty are conventional treatments for ischemic heart disease, with ongoing research into optimal strategies.
• The use of arterial grafts in bypass surgery is strongly supported by evidence.
• Alternative and novel therapies, including angiogenic and gene therapies, are being explored for patients with diffuse disease, with less invasive techniques potentially aiding delivery.

Impact:

• Highlights the established benefits of arterial conduits in surgical revascularization.
• Identifies the need for further research into comparative effectiveness of revascularization strategies.
• Suggests future directions in treating complex ischemic heart disease with novel and minimally invasive approaches.